Gait disorders

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 5, 2013, Pages 1344-1382

  Fasano, Alfonso ^a   Bloem, Bastiaan R ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; BACLOFEN; BOTULINUM TOXIN; DANTROLENE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; METHYLPHENIDATE; SELEGILINE; TIZANIDINE;

AMBULATORY MONITORING; ATTENTION DEFICIT DISORDER; BABINSKI REFLEX; BRAIN VENTRICLE PERITONEUM SHUNT; CENTRAL PATTERN GENERATOR; CEREBELLAR ATAXIA; CEREBELLUM CORTEX; CEREBROSPINAL FLUID SHUNTING; CHOREA; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COGNITION; DEPTH PERCEPTION; DISEASE DURATION; DIZZINESS; DOPAMINERGIC NERVE CELL; DORSAL RHIZOTOMY; DRUG INDUCED HEADACHE; DYSTONIA; ESSENTIAL TREMOR; FALLING; FREEZING OF GAIT; GAIT; GAIT DISORDER; HUMAN; INSOMNIA; LOCOMOTION; LOCUS CERULEUS; LUMBAR PUNCTURE; MENTAL FUNCTION; MUSCLE STRENGTH; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROLOGIC GAIT DISORDER; NONHUMAN; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PERIODIC PARALYSIS; PHENOMENOLOGY; PHENOTYPE; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PREMOTOR CORTEX; PRIMARY LATERAL SCLEROSIS; PROGRESSIVE SUPRANUCLEAR PALSY; PSEUDOBULBAR PALSY; QUALITY OF LIFE; RANGE OF MOTION; REVIEW; SHY DRAGER SYNDROME; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPASTICITY; SUBSTANTIA NIGRA PARS RETICULATA; SUPPLEMENTARY MOTOR AREA; URINARY TRACT INFECTION; VISUAL HALLUCINATION; WALKING;

AGED; ANTI-DYSKINESIA AGENTS; BRAIN STEM; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE AGENTS; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; LOCOMOTION; MALE; MIDDLE AGED; MOVEMENT DISORDERS; NEUROLOGIC EXAMINATION; PARASYMPATHOLYTICS; PARKINSONIAN DISORDERS; POSTURAL BALANCE; SPINAL CORD;

EID: 84885584054     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000436159.33447.69     Document Type: Review

References (65)

1. Stolze H, Klebe S, Baecker C, et al. Prevalence of gait disorders in hospitalized neurological patients. Mov Disord 2005; 20(1):89-94. (Pubitemid 40277513)
2. Snijders AH, Leunissen I, Bakker M, et al. Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait. Brain 2011;134(pt 1):59-72.
3. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 2000;123(pt 9): 1767-1783. (Pubitemid 30664282)
4. Piallat B, Chabardes S, Torres N, et al. Gait is associated with an increase in tonic firing of the sub-cuneiform nucleus neurons. Neuroscience 2009;158(4):1201-1205.
5. Nutt JG, Horak FB, Bloem BR. Milestones in gait, balance, and falling. Mov Disord 2011;26(6):1166-1174.
6. Nutt JG, Marsden CD, Thompson PD. Human walking and higher-level gait disorders, particularly in the elderly. Neurology 1993;43(2):268-279. (Pubitemid 23060255)
7. Snijders AH, van deWarrenburg BP, Giladi N, Bloem BR. Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol 2007;6(1):63-74. (Pubitemid 44895449)
8. Snijders AH, Bloem BR. Images in clinical medicine. Cycling for freezing of gait. N Engl J Med 2010;362(13):e46.
9. Bakker M, Allum JH, Visser JE, et al. Postural responses to multidirectional stance perturbations in cerebellar ataxia. Exp Neurol 2006;202(1):21-35. (Pubitemid 44344244)
10. Fasano A, Herzog J, Raethjen J, et al. Lower limb joints kinematics in essential tremor and the effect of thalamic stimulation. Gait Posture 2012;36(2):187-193.
11. Morton SM, Bastian AJ. Relative contributions of balance and voluntary leg-coordination deficits to cerebellar gait ataxia. J Neurophysiol 2003;89(4):1844-1856. (Pubitemid 36444240)
12. Morris ME, Iansek R, Matyas TA, Summers JJ. Ability to modulate walking cadence remains intact in Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57(12): 1532-1534.
13. Ruzicka E, Zarubova K, Nutt JG, Bloem BR. ''Silly walks'' in Parkinson's disease: unusual presentation of dopaminergicinduced dyskinesias. Mov Disord 2011; 26(9):1782-1784.
14. Bovi T, Fasano A, Juergenson I, et al. Paroxysmal exercise-induced dyskinesia with self-limiting partial epilepsy: a novel GLUT-1 mutation with benign phenotype. Parkinsonism Relat Disord 2011;17(6): 479-481.
15. Fasano A, Ruzicka E, Bloem BR. Tic-induced gait dysfunction. Mov Disord 2012;27(7):911-913.
16. Doherty KM, van de Warrenburg BP, Peralta MC, et al. Postural deformities in Parkinson's disease. Lancet Neurol 2011; 10(6):538-549.
17. Schniepp R, Wuehr M, Neuhaeusser M, et al. Locomotion speed determines gait variability in cerebellar ataxia and vestibular failure. Mov Disord 2012;27(1):125-131.
18. Chee R, Murphy A, Danoudis M, et al. Gait freezing in Parkinson's disease and the stride length sequence effect interaction. Brain 2009;132(pt 8):2151-2160.
19. Lundin-Olsson L, Nyberg L, Gustafson Y. ''Stops walking when talking'' as a predictor of falls in elderly people. Lancet 1997; 349(9052):617. (Pubitemid 27101891)
20. Bloem BR, Grimbergen YA, van Dijk JG, Munneke M. The ''posture second'' strategy: a review of wrong priorities in Parkinson's disease. J Neurol Sci 2006; 248(1-2):196-204. (Pubitemid 44647282)
21. Abdo WF, Borm GF, Munneke M, et al. Ten steps to identify atypical parkinsonism. J Neurol Neurosurg Psychiatry 2006;77(12): 1367-1369. (Pubitemid 44851998)
22. Giladi N, Nieuwboer A. Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov Disord 2008;23(suppl 2): S423-S425.
23. Nutt JG, Bloem BR, Giladi N, et al. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol 2011;10(8):734-744.
24. Jacobs JV, Nutt JG, Carlson-Kuhta P, et al. Knee trembling during freezing of gait represents multiple anticipatory postural adjustments. Exp Neurol 2009;215(5): 334-341.
25. Nieuwboer A, Vercruysse S, Feys P, et al. Upper limb movement interruptions are correlated to freezing of gait in Parkinson's disease. Eur J Neurosci 2009;29(7):1422-1430.
26. Plotnik M, Giladi N, Balash Y, et al. Is freezing of gait in Parkinson's disease related to asymmetric motor function? Ann Neurol 2005;57(5):656-663. (Pubitemid 40628854)
27. Plotnik M, Giladi N, Hausdorff JM. Bilateral coordination of walking and freezing of gait in Parkinson's disease. Eur J Neurosci 2008;27(8):1999-2006. (Pubitemid 351521485)
28. Amboni M, Cozzolino A, Longo K, et al. Freezing of gait and executive functions in patients with Parkinson's disease. Mov Disord 2008;23(3):395-400.
29. Cohen RG, Horak FB, Nutt JG. Peering through the FoG: visual manipulations shed light on freezing of gait. Mov Disord 2012;27(4):470-472.
30. Espay AJ, Fasano A, van Nuenen BF, et al. ''On'' state freezing of gait in Parkinson disease: a paradoxical levodopa-induced complication. Neurology 2012;78(7):454-457.
31. Schaafsma JD, Giladi N, Balash Y, et al. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci 2003;212(1-2):47-53. (Pubitemid 36693964)
32. Giladi N, McDermott MP, Fahn S, et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 2001;56(12):1712-1721. (Pubitemid 32574572)
33. Sudarsky L, Ronthal M. Gait disorders among elderly patients. A survey study of 50 patients. Arch Neurol 1983;40(12): 740-743. (Pubitemid 14230511)
34. Zadikoff C, Lang AE. Apraxia in movement disorders. Brain 2005;128(pt 7):1480-1497 (Pubitemid 41373669)
35. Sasaki M, Honda S, Yuasa T, et al. Narrow CSF space at high convexity and high midline areas in idiopathic normal pressure hydrocephalus detected by axial and coronal MRI. Neuroradiology 2008;50(2): 117-122.
36. Glass PG, Lees AJ, Bacellar A, et al. The clinical features of pathologically confirmed vascular parkinsonism. J Neurol Neurosurg Psychiatry 2012;83(10):1027-1029.
37. Factora R, Luciano M. When to consider normal pressure hydrocephalus in the patient with gait disturbance. Geriatrics 2008;63(2):32-37. (Pubitemid 351413740)
38. Stolze H, Kuhtz-Buschbeck JP, Drucke H, et al. Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70(3):289-297. (Pubitemid 32250883)
39. Krauss JK, Regel JP, Droste DW, et al. Movement disorders in adult hydrocephalus. Mov Disord 1997;12(1):53-60. (Pubitemid 27032880)
40. Relkin N, Marmarou A, Klinge P, et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57(3 suppl): S4-S16; discussion iiYv.
41. Morishita T, Foote KD, Okun MS. INPH and Parkinson disease: differentiation by levodopa response. Nat Rev Neurol 2010;6(1):52-56.
42. Klassen BT, Ahlskog JE. Normal pressure hydrocephalus: how often does the diagnosis hold water? Neurology 2011; 77(12):1119-1125.
43. Magdalinou NK, Ling H, Smith JD, et al. Normal pressure hydrocephalus or progressive supranuclear palsy? A clinicopathological case series. J Neurol 2013;260(4):1009-1013.
44. Leinonen V, Koivisto AM, Savolainen S, et al. Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature. Neuropathol Appl Neurobiol 2012;38(1):72-86.
45. Factor SA, Higgins DS, Qian J. Primary progressive freezing gait: a syndrome with many causes. Neurology 2006;66(3):411-414. (Pubitemid 43739946)
46. Mabuchi N, Watanabe H, Atsuta N, et al. Primary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement. J Neurol Neurosurg Psychiatry 2004;75(12):1768-1771. (Pubitemid 39611485)
47. Fasano A, Baldari S, Di Giuda D, et al. Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis. Parkinsonism Relat Disord 2012;18(5):578-584.
48. Bloem BR, Haan J, Lagaay AM, et al. Investigation of gait in elderly subjects over 88 years of age. J Geriatr Psychiatry Neurol 1992;5(2):78-84.
49. Baik JS, Lang AE. Gait abnormalities in psychogenic movement disorders. Mov Disord 2007;22(3):395-399. (Pubitemid 46569698)
50. Lempert T, Brandt T, Dieterich M, Huppert D. How to identify psychogenic disorders of stance and gait. A video study in 37 patients. J Neurol 1991;238(3):140-146.
51. Voermans NC, Zwarts MJ, van Laar T, et al. Fallacious falls. J Neurol 2005;252(10): 1271-1273.
52. Giladi N. Medical treatment of freezing of gait. Mov Disord 2008;23(suppl 2):S482-S488.
53. Moreau C, Delval A, Defebvre L, et al. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol 2012;11(7):589-596.
54. Narabayashi H, Kondo T, Yokochi F, Nagatsu T. Clinical effects of l-threo-3, 4-dihydroxyphenylserine in cases of parkinsonism and pure akinesia. Adv Neurol 1987;45:593-602.
55. Morgante F, Fasano A. Improvement with duloxetine in primary progressive freezing gait. Neurology 2010;75(23):2130-2132.
56. Zuniga C, Lester J, Cersosimo MG, et al. Treatment of primary progressive freezing of gait with high doses of selegiline. Clin Neuropharmacol 2006;29(1):20-21. (Pubitemid 44378607)
57. Gurevich T, Peretz C, Moore O, et al. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study. Mov Disord 2007;22(6):880-883. (Pubitemid 46800116)
58. Ben-Itzhak R, Giladi N, Gruendlinger L, Hausdorff JM. Can methylphenidate reduce fall risk in community-living older adults? A double-blind, single-dose cross-over study. J Am Geriatr Soc 2008;56(4):695-700. (Pubitemid 351473517)
59. Chung KA, Lobb BM, Nutt JG, Horak FB. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 2010;75(14):1263-1269.
60. Goodman AD, Stone RT. Enhancing neural transmission in multiple sclerosis (4-aminopyridine therapy).Neurotherapeutics 2013;10(1):106-110.
61. Ferraye MU, Debu B, Fraix V, et al. Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease. Neurology 2008;70(16 pt 2): 1431-1437. (Pubitemid 351521936)
62. Moreau C, Defebvre L, Destee A, et al. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 2008;71(2):80-84.
63. St George RJ, Nutt JG, Burchiel KJ, Horak FB. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology 2010;75(14): 1292-1299.
64. Fasano A, Deuschl G. Patients and DBS targets: Is there any rationale for selecting them? Basal Ganglia 2012;2:211-219.
65. Fasano A, Daniele A, Albanese A. Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Lancet Neurol 2012;11(5):429-442.